Friday, 27 January 2012

5th Advances Against Aspergillosis Conference: Day 2

Programme
Go directly to a day's programme Thursday | Friday | Saturday


Friday 27 January 2012 – Day 2  


Session 6: Astellas Symposium
Chair: Katsuhiko Kamei, MD, PhD

08.00 – 09.00      Controversies in management: prophylaxis or diagnostics
                          Andrew Ullman, MD
                          Drosos E. Karageorgopoulos, MD


Session 7: Genomics and Proteomics
Chairs: Elaine Bignell, PhD & David S. Perlin, PhD

09.15 – 09.40      Aspergillus adhesions
                          Don Sheppard, MD

09.40 – 10.05      mRNAs in Aspergillus
                          Michelle Momany, PhD

10.05 – 10.30      RNAseq
                          Antonis Rokas, PhD

10.30 – 10.55      Alternative approaches to drug discovery in Aspergillus fumigatus
                          Michael Bromley, PhD

10.55 – 11.20      Targets for broad spectrum antifungal vaccines? Quantitative proteomic comparisons of Aspergillus & Co.
                          Markus Kalkum, PhD


11.20 – 11.50      Coffee / Tea Break


Session 8: Management of Aspergillosis
Chairs: John E. Bennett, MD & Volkan Korten, MD

11.50 – 12.15      Management of chronic pulmonary aspergillosis
                          Koichi Izumikawa, MD, PhD

12.15 – 12.40      Update on biologicals for ABPA and asthma
                          Richard B. Moss, MD

12.40 – 13.05      Paediatric aspergillosis
                          Andreas Groll, MD

13.05 – 13.15      Aspergillus bronchitis in non-immunocompromised patients – case series, response to treatment and criteria for diagnosisTimothy Felton, MD


13.15 – 14.15      Lunch


14.15                  CONFERENCE SOCIAL EVENT: Tours followed by Dinner

No comments:

Amazon Contextual Product Ads

Contact us at admin@aspergillus.org.uk